Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is erectile dysfunction a marker for cardiovascular disease?

M Kirby1, G Jackson, J Betteridge

  • 1Department of Cardiology, Guy's Hospital, London, UK.

International Journal of Clinical Practice
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stop: the medical and human rights scandal in Bahrain.

International journal of clinical practice·2011
Same author

Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2011
Same author

Transferable SAFT-VR models for the calculation of the fluid phase equilibria in reactive mixtures of carbon dioxide, water, and n-alkylamines in the context of carbon capture.

The journal of physical chemistry. B·2011
Same author

Structural and functional failure of TVT by trimming of the extruded edge.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2011
Same author

Cholesteric order in systems of helical Yukawa rods.

Journal of physics. Condensed matter : an Institute of Physics journal·2011
Same author

Communicating about death and dying.

International journal of clinical practice·2011
Same journal

RETRACTION: Prediction of Arrhythmia Recurrence after Atrial Fibrillation Ablation in Patients with Normal Anatomy of the Left Atrium.

International journal of clinical practice·2025
Same journal

Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice.

International journal of clinical practice·2025
Same journal

Knowledge and Awareness of Osteoporosis: A Survey of Physical Therapy Providers in Saudi Arabia.

International journal of clinical practice·2024
Same journal

Efficacy and Safety of Pericapsular Nerve Group Block for Hip Fracture Surgery under Spinal Anesthesia: A Meta-Analysis.

International journal of clinical practice·2024
Same journal

The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.

International journal of clinical practice·2024
Same journal

Blood Features Associated with Viral Infection Severity: An Experience from COVID-19-Pandemic Patients Hospitalized in the Center of Iran, Yazd.

International journal of clinical practice·2024
See all related articles

Erectile dysfunction (ED) is a key indicator of cardiovascular disease. Making ED treatments more accessible on the NHS could encourage early disease detection and improve heart health outcomes.

Area of Science:

  • Cardiology
  • Urology
  • Public Health

Background:

  • Erectile dysfunction (ED) is increasingly recognized as a significant symptom and marker for cardiovascular disease (CVD).
  • National Health Service (NHS) policies on prescribing ED treatments have been reviewed, with no changes to current restrictions.
  • Early detection of CVD is a public health priority, particularly concerning National Service Framework targets for coronary heart disease.

Purpose of the Study:

  • To evaluate the potential impact of unrestricted NHS availability of ED treatments on early cardiovascular disease detection.
  • To explore how ED treatments, such as sildenafil citrate, might influence the achievement of cardiovascular health targets.
  • To assess the role of ED as an early warning sign for underlying cardiovascular conditions.

Main Methods:

Related Experiment Videos

  • Review of current evidence linking ED to cardiovascular disease.
  • Analysis of National Health Service (NHS) prescribing policies for ED treatments.
  • Consideration of the pharmacological effects of sildenafil citrate on cardiovascular health.

Main Results:

  • Significant evidence supports ED as a symptom and progression marker for cardiovascular disease.
  • Current NHS prescribing restrictions for ED treatments remain unchanged.
  • Sildenafil citrate, an ED treatment, demonstrates potential direct benefits for cardiovascular disease.

Conclusions:

  • Unrestricted NHS access to ED treatments could incentivize men to seek medical evaluation, facilitating earlier cardiovascular disease diagnosis.
  • Wider availability of ED therapies may contribute to achieving National Service Framework goals for coronary heart disease.
  • ED serves as a crucial, yet often overlooked, early indicator for underlying cardiovascular pathology.